Medicinal composition
Abstract
The present invention relates to an ameliorant for improving the movement of the digestive tract comprising, as an active ingredient, 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-2-hydroxymethyl-4-pyrrolidinyl]benzamide or an acid addition salt thereof which is a metabolite of 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-1-ethyl-2-hydroxymethyl-4-pyrrolidinyl]benzamide or an acid addition salt thereof, having high biding affinity for a serotonin receptor 4 (5HT 4 ) and causing no arteritis and thrombus formation; a medicinal composition for improving the movement of the digestive tract comprising the said ameliorant and a pharmaceutically acceptable carrier; and a treating method for promoting the movement of the digestive tract, which comprises using the said medicinal composition for improving the movement of the digestive tract.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A medicinal composition for improving the movement of the digestive tract, comprising as an active ingredient 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-2-hydroxymethyl-4-pyrrolidinyl]benzamide or an acid addition salt thereof which has high binding affinity for a serotonin receptor 4 (5HT 4 ) and does not cause arteritis and thrombus formation, and a pharmaceutically acceptable carrier.
3 - 4 . (canceled)
5 . 4-Amino-5-chloro-2-methoxy-N-[(2S,4S)-2-hydroxymethyl-4-pyrrolidinyl]benzamide or an acid addition salt thereof.
6 . 4-Amino-5-chloro-2-methoxy-N-[(2S,4S)-2-hydroxymethyl-4-pyrrolidinyl]benzamide in which an amino group at position 4 or/and an amino group of the pyrrolidinyl group is optionally protected, or an acid addition salt thereof.
7 . A process for preparing 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-2-hydroxymethyl-4-pyrrolidinyl]benzamide or an acid addition salt thereof, which comprises reacting 4-amino-5-chloro-2-methoxybenzoic acid having an optionally protected amino group, or a reactive derivative thereof with (2S,4S)-4-amino-N-acyl-2-hydroxymethylpyrrolidine to obtain 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-1-acyl-2-hydroxymethyl-4-pyrrolidinyl]benzamide or an acid addition salt thereof, and eliminating a protecting group and the acyl group, when a protecting group is used in the acyl group.
8 . (2S,4S)-4-amino-N-acyl-2-hydroxymethylpyrrolidine having an optionally protected amino group.
9 . The compound according to claim 8 , wherein a protecting group for an amino group is an acyl group, and the said acyl group and an acyl group of N-acyl are selected from formyl, acetyl, propionyl and benzoyl.
10 . The compound according to claim 8 , wherein the acyl group is acetyl.Join the waitlist — get patent alerts
Track US2009118353A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.